{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:07:50Z","timestamp":1775470070283,"version":"3.50.1"},"reference-count":152,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T00:00:00Z","timestamp":1204502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Current treatment regimens for haematological autoimmune diseases are relatively non\u2010selective and are often associated with considerable toxicity. Recently, it has become clear that B cells play a key role in both the development and perpetuation of autoimmunity, suggesting that B\u2010cell depletion could be a valuable treatment approach for patients with autoimmune diseases. This article reviews data supporting the use of rituximab \u2013 an anti\u2010CD20 monoclonal antibody that specifically depletes B cells \u2013 in four key autoimmune haematological disorders: idiopathic thrombocytopenic purpura (ITP); autoimmune haemolytic anaemia (AIHA); acquired haemophilia; and thrombotic thrombocytopenic purpura (TTP). Although treatment of ITP, AIHA, acquired haemophilia and TTP with rituximab is still relatively uncommon, results from case series and small phase II trials indicate that patients of all ages can respond to rituximab, irrespective of the number or type of prior treatments that they have received. Moreover, patients with these diseases receiving rituximab experienced predominantly mild adverse events, with only a few serious adverse events reported. These data suggest that rituximab provides an effective and well\u2010tolerated alternative treatment option for patients with ITP, AIHA, acquired haemophilia and TTP, many of whom have limited treatment choices.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07054.x","type":"journal-article","created":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T00:06:12Z","timestamp":1204589172000},"page":"149-169","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Rituximab in the treatment of autoimmune haematological disorders"],"prefix":"10.1111","volume":"141","author":[{"given":"Bernadette","family":"Garvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,18]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01611.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01060.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20166"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190701411441"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029607303777"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-1-200701020-00006"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2004.tb02989.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.2006.00794.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3518"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3597"},{"key":"e_1_2_6_12_1","first-page":"460","article-title":"Primary chronic cold agglutinin disease: a population based clinical study of 86 patients","volume":"91","author":"Berentsen S.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2006.00669.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2001.0904"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200312001-00007"},{"key":"e_1_2_6_16_1","first-page":"965","article-title":"Timing of plasma exchange and rituximab for the treatment of thrombotic thrombocytopenic purpura","volume":"126","author":"Boctor F.N.","year":"2006","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-0734.2001.00049.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.83.3.220"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-12-199312150-00007"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20276"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2006.00720.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.4065\/81.3.377"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10204"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2007.01338.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4598"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.01.009"},{"key":"e_1_2_6_28_1","first-page":"72","article-title":"B\u2010cell depletion for rheumatic diseases: where are we?","volume":"7","author":"Cohen S.B.","year":"2005","journal-title":"MedGenMed: Mediscape General Medicine"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22025"},{"key":"e_1_2_6_30_1","doi-asserted-by":"crossref","first-page":"98a","DOI":"10.1182\/blood.V106.11.322.322","article-title":"UKHCDO Acquired Haemophilia Study: a complete national cohort","volume":"106","author":"Collins P.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2003.50004"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04889.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e3282c8ca50"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666060-00005"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20665"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00861.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/RLNMJ01WBJRNLH03","article-title":"Rituximab can be combined with daily plasma exchange to achieve effective B\u2010cell depletion and clinical improvement in acute autoimmune TTP","volume":"125","author":"Darabi K.","year":"2006","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04162.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534"},{"issue":"1","key":"e_1_2_6_40_1","first-page":"79","article-title":"A fixed, low dose of anti\u2010CD20 antibody (Rituximab) is an effective treatment for patients with chronic immune thrombocytopenia","volume":"133","author":"El\u2010Najjar I.","year":"2006","journal-title":"British Journal of Haematology"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21778"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2006.n.033"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-0848"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01342.x"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3920"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.909.415k02_909_913"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.5414\/NPP26068"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4885"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0317-3"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10062"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.4.1223"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311807"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2002.1.315"},{"key":"e_1_2_6_54_1","first-page":"439","article-title":"Cold agglutinin disease","volume":"91","author":"Gertz M.A.","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.02686.x"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2005.17.4.449"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.12.038"},{"key":"e_1_2_6_58_1","doi-asserted-by":"crossref","first-page":"145a","DOI":"10.1182\/blood.V108.11.478.478","article-title":"Rituximab is an alternative to splenectomy in adults with chronic immune thrombocytopenic purpura: results of a multicenter prospective Phase 2 study. ASH Annual Meeting Abstracts","volume":"108","author":"Godeau B.","year":"2006","journal-title":"Blood"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.4.1486"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650169"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402676"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2002.0522"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.191"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06087.x"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH06-09-0499"},{"key":"e_1_2_6_66_1","first-page":"215","article-title":"Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab","volume":"4","author":"Herbei L.","year":"2006","journal-title":"Clinical Advances in Hematology & Oncology"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01089.x"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01136.x"},{"key":"e_1_2_6_69_1","first-page":"210","article-title":"Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura","volume":"4","author":"Hull M.J.","year":"2006","journal-title":"Clinical Advances in Hematology & Oncology"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X80224"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1159\/000070973"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03835_5.x"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0631-0"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2007.22.3.420"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05681.x"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2005.05.007"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.04.003"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.04187"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20243"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000267325.06000.d9"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0461-8"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01425.x"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200559"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.10.863"},{"key":"e_1_2_6_85_1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.1987.00370060073014","article-title":"Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy","volume":"147","author":"Lottenberg R.","year":"1987","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.432"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.06.068"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00038.x"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(04)00112-8"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20887"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00829.x"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00560.x"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020528"},{"key":"e_1_2_6_94_1","first-page":"136","article-title":"Management of adult idiopathic thrombocytopenic purpura","volume":"4","author":"Nakhoul I.N.","year":"2006","journal-title":"Clinical Advances in Hematology & Oncology"},{"key":"e_1_2_6_95_1","first-page":"1273","article-title":"Rituximab in the treatment of refractory autoimmune cytopenias in adults","volume":"90","author":"Narat S.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04547.x"},{"key":"e_1_2_6_97_1","first-page":"1194","article-title":"Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease","volume":"33","author":"Niewold T.B.","year":"2006","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20830"},{"key":"e_1_2_6_99_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-021113"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000260656.05638.f7"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH06-03-0183"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20678"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-006-9051-2"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.E0518"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20113"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-005-0073-1"},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci130"},{"key":"e_1_2_6_108_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200111000-00016"},{"key":"e_1_2_6_109_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03537_6.x"},{"key":"e_1_2_6_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06573-4"},{"key":"e_1_2_6_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21264"},{"key":"e_1_2_6_112_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.55.091902.104249"},{"key":"e_1_2_6_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0964-6"},{"key":"e_1_2_6_114_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.435.435"},{"key":"e_1_2_6_115_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40080896.x"},{"key":"e_1_2_6_116_1","volume-title":"Autoimmune Diseases","author":"Rose N.R.","year":"1998"},{"key":"e_1_2_6_117_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2004.1.407"},{"issue":"12","key":"e_1_2_6_118_1","first-page":"99","article-title":"A pilot study of the anti\u2010CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia","volume":"27","author":"Saleh M.N.","year":"2000","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_119_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01149.x"},{"key":"e_1_2_6_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00678.x"},{"key":"e_1_2_6_121_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2516.2007.01587.x","article-title":"Efficacy of rituximab treatment in postpartum acquired haemophilia\u2003A","volume":"14","author":"Santoro C.","year":"2007","journal-title":"Haemophilia"},{"key":"e_1_2_6_122_1","first-page":"65","article-title":"Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002\u20132004)","volume":"24","author":"Scheinberg M.","year":"2006","journal-title":"Clinical and Experimental Rheumatology"},{"key":"e_1_2_6_123_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20764"},{"key":"e_1_2_6_124_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500286481"},{"key":"e_1_2_6_125_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0335-1"},{"key":"e_1_2_6_126_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06448.x"},{"key":"e_1_2_6_127_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094839"},{"key":"e_1_2_6_128_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2005.04.002"},{"key":"e_1_2_6_129_1","doi-asserted-by":"publisher","DOI":"10.4065\/78.11.1340"},{"key":"e_1_2_6_130_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10947"},{"key":"e_1_2_6_131_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.45.12.1047"},{"key":"e_1_2_6_132_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.952"},{"key":"e_1_2_6_133_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0392"},{"key":"e_1_2_6_134_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-4075"},{"key":"e_1_2_6_135_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-068999"},{"key":"e_1_2_6_136_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.E0403"},{"key":"e_1_2_6_137_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000078897.11633.5F"},{"key":"e_1_2_6_138_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15255"},{"key":"e_1_2_6_139_1","first-page":"281","article-title":"Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood","volume":"90","author":"Taube T.","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_6_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0424"},{"key":"e_1_2_6_141_1","first-page":"223","article-title":"Rituximab chimeric anti\u2010CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders","volume":"88","author":"Trap\u00e8 G.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_6_142_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000060805.04118.4C"},{"key":"e_1_2_6_143_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01350.x"},{"key":"e_1_2_6_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.09.004"},{"key":"e_1_2_6_145_1","doi-asserted-by":"publisher","DOI":"10.1159\/000089464"},{"key":"e_1_2_6_146_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0765"},{"key":"e_1_2_6_147_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04836.x"},{"key":"e_1_2_6_148_1","first-page":"538","article-title":"B\u2010cell compartment as the selective target for the treatment of immune thrombocytopenias","volume":"88","author":"Zaja F.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_6_149_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000119235"},{"key":"e_1_2_6_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.02.009"},{"key":"e_1_2_6_151_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3547"},{"key":"e_1_2_6_152_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb01887.x"},{"key":"e_1_2_6_153_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-2-200301210-00011"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07054.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07054.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:41:33Z","timestamp":1697420493000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07054.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,18]]},"references-count":152,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07054.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07054.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,18]]},"assertion":[{"value":"2008-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}